Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 13/20 | 0.56 |
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.56 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.38 |
| ▸ | P4HB | P07237 | 1/20 | 0.37 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL47074 | 0.92 | LPL (0.53) | LPLLIPGIRAK4CA1CA2 | |
| SCHEMBL10074112 | 0.90 | LPL (0.48) | LPLLIPGIRAK4CA1CA2 | |
| SCHEMBL10074115 | 0.90 | LPL (0.48) | LPLLIPGIRAK4CA1CA2 | |
| SCHEMBL19916979 | 0.84 | LPL (0.48) | LPLLIPGIRAK4P4HBROCK1 | |
| SCHEMBL16863588 | 0.83 | LIPG (0.66) | LPLLIPGDGAT1P4HBROCK1 | |
| SCHEMBL29392121 | 0.81 | LPL (0.75) | LPLLIPGIRAK4CA1CA2 | |
| SCHEMBL120527 | 0.81 | LPL (0.75) | LPLLIPGIRAK4CA1CA2 | |
| SCHEMBL20230728 | 0.81 | AHR (0.55) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL13142480 | 0.80 | LPL (0.68) | LPLLIPGIRAK4CA1CA2 | |
| SCHEMBL22337014 | 0.79 | LPL (0.45) | LPLLIPGIRAK4CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10249830-B2 | Carbazole-based compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-04-02 | — | — | US | disclosed |
| WO-2018038464-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 주식회사 두산 | 2018-03-01 | — | — | WO | disclosed |
| US-20170077419-A1 | CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-03-16 | — | — | US | disclosed |
| US-20170077419-A1 | CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-03-16 | — | — | US | disclosed |
| WO-2016105072-A2 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | 주식회사 두산 | 2016-06-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10249830-B2 | Carbazole-based compound and organic light-emitting device including the same | OCIAD1, OXA1L, OCIAD2 | LPL 2018/4885LIPG 3590/4885IRAK4 2061/4885 |
| US-20170077419-A1 | CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | OCIAD1, OXA1L, CYP1A1 | LPL 1956/4885LIPG 3515/4885IRAK4 1895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.